Search Orphan Drug Designations and Approvals
-
Generic Name: | Corneal Endothelial Cells Substitute derived from human allogeneic iPS Cells (CECSi) |
---|---|
Date Designated: | 12/20/2023 |
Orphan Designation: | Treatment of bullous keratopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Cellusion, Inc. #801, 8-6 Nihonbashi-Kobunacho, Chuo-ku, Tokyo 103-0024 Japan The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-